Biogen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

15.06.17	Pharmaceutical Leaders Pave the Way to New Alzheimer's Treatments (PR Newswire)
14.06.17	Alexion Pharma Appoints Biogen Executive Paul Clancy As CFO (RTTNews)
14.06.17	Biogen CFO Paul Clancy To Step Down (RTTNews)
01.06.17	Biogen Reports Marketing Authorization For SPINRAZA In European Union (RTTNews)
24.05.17	Biogen's FAMPYRA Granted MA In EU For Improvement Of Walking In People With MS (RTTNews)
24.05.17	Biogen’s FAMPYRA® Granted Standard Marketing Authorization in European Union for Improvement of Walking in People with MS (Businesswire)
18.05.17	Biogen Buys Remedy Pharma' Late-Stage Drug CIRARA (RTTNews)
16.05.17	Biotech Stocks Under Scanner -- BioCryst Pharma, Biogen, Celldex Therapeutics, and Concordia (PR Newswire)
25.04.17	MÄRKTE USA/Quartalsberichte treiben Kurse - Nasdaq über 6.000 (Dow Jones)
25.04.17	MÄRKTE USA/Wall Street setzt Rally fort - Nasdaq erstmals über 6.000 (Dow Jones)
25.04.17	MÄRKTE USA: Wall Street dürfte mehrere Gänge zurückschalten (Dow Jones)
25.04.17	Biogen Inc. Q1 Earnings Climb 7% (RTTNews)
24.04.17	Biogen: TECFIDERA, TYSABRI Data Show Improved Outcomes With Early MS Treatment (RTTNews)
13.04.17	Bristol-Myers To Get $470 Mln Upfront From Licensing Deals With Biogen, Roche (RTTNews)
17.03.17	5 Biotech Companies Set for Major Breakouts in 2017 (PR Newswire)
01.03.17	Biotech Stocks Under Scanner -- Immunomedics, Peregrine Pharma, Vericel, and Biogen (PR Newswire)
27.02.17	Perrigo To Divest Its Rights To Royalty Stream From Tysabri To Royalty Pharma (RTTNews)
25.02.17	Biotechnologie-Aktien: Wo es frische Kaufsignale gibt (finanzen.ch)
09.02.17	Forward Pharma Gets $1.25 Bln On Settlement And License Deal With Biogen (RTTNews)
26.01.17	Biogen-Gewinn schrumpft nach Lizenzstreit um Tecfidera (AWP)
26.01.17	Biogen Sees FY17 Earnings In-line With Estimates, Revenues Below View (RTTNews)
26.01.17	Biogen Inc. Reports 9% Gain In Q4 Profit (RTTNews)
25.01.17	LogMeIn and Bioverativ Set to Join the S&P MidCap 400; Others to Join S&P SmallCap 600 (PR Newswire)
17.01.17	Biogen To Pay $1.25 Bln For Forward Pharma Intellectual Property - Quick Facts (RTTNews)
13.01.17	Biogen Presents New Data From Phase 3 ENDEAR Study Of SPINRAZA (RTTNews)
11.01.17	Technical Reports on Biotech Stocks -- Biogen, Alnylam Pharma, Cascadian Therapeutics, and Marinus Pharma (PR Newswire)
28.12.16	Biogen, Ionis Get FDA Approval For SMA Drug (RTTNews)
24.12.16	IONS Scripts History, PTLA Gets FDA Date, Strongbridge Slumps, NEOT On Watch (RTTNews)
22.12.16	Revolt PR: The First Millennial Agency (PR Newswire)
20.12.16	Biogen’s Board of Directors Approves Separation of Bioverativ and Declares Special Dividend Distribution of Bioverativ Stock (Businesswire)
20.12.16	Biogen Names Chief Commercial Officer Michel Vounatsos As New CEO (RTTNews)
19.12.16	SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Biogen Inc. To Contact The Firm Before Imminent Lead Plaintiff Deadline (PR Newswire)
12.12.16	Cliffs Natural Resources, Tesla Motors, Biogen, Coca-Cola, and Nordstrom and more offer option-trading opportunities that offer returns of more than 19% (PR Newswire)
09.12.16	MÄRKTE USA/Wall Street steigt auf immer neue Rekorde (Dow Jones)
09.12.16	Biogen And AbbVie Receive Health Canada Approval Of Once-Monthly ZINBRYTA (RTTNews)
30.11.16	BIIB INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Biogen Inc. and a Lead Plaintiff Deadline of December 23, 2016 (PR Newswire)
30.11.16	Research Reports Coverage on Biotech Stocks -- Biogen, BioMarin Pharma, Seattle Genetics, and Grifols (PR Newswire)
23.11.16	MÄRKTE USA/Dow trotzt Verschnaufpause und steigt weiter (Dow Jones)
09.11.16	US-WAHL/Markt-Ticker: US-Pharmawerte profitieren von Trump-Sieg (dpa-afx)
07.11.16	Biogen & Ionis: SPINRAZA Meets Primary Endpoint In Phase 3 Study - Quick Facts (RTTNews)
31.10.16	BIIB To Face FDA, It's A Thumb Down For REGN, STJ Meets Trial Goal (RTTNews)
28.10.16	Biogen Says FDA Accepts Its NDA For Nusinersen (RTTNews)
26.10.16	Multiple-Sklerose-Mittel halten Biogen auf Kurs (dpa-afx)
26.10.16	Multiple-Sklerose-Mittel halten Biogen auf Kurs (AWP)
26.10.16	Biogen Inc. Q3 Profit Rises 10% (RTTNews)
15.09.16	Biogen Reveals Positive Result For Phase 3 Trial Of Zinbryta In MS Patients (RTTNews)
15.09.16	New Data Presented at ECTRIMS Reinforce Efficacy of ZINBRYTA™ (Daclizumab) and Support Long-Term Safety Profile (Businesswire)
14.09.16	Biogen Reveales Efficacy, Safety Data For Tecfidera In MS Trials (RTTNews)
14.09.16	New Data Affirm Strong Efficacy and Well-Characterized Safety Profile of TECFIDERA® in Both Clinical Studies and Real-World Setting (Businesswire)
31.08.16	Nature Publishes Results from Pre-Clinical Research and Phase 1b Study of Biogen’s Investigational Alzheimer’s Disease Treatment Aducanumab (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

24.12.24		Börse New York: Dow Jones zeigt sich zum Handelsende fester
24.12.24		Zuversicht in New York: Dow Jones am Dienstagnachmittag mit Gewinnen
24.12.24		Dow Jones-Handel aktuell: Dow Jones steigt am Dienstagmittag
24.12.24		Börse New York: NASDAQ 100-Anleger greifen am Dienstagmittag zu
24.12.24		Freundlicher Handel: Letztendlich Gewinne im Euro STOXX 50
24.12.24		Dienstagshandel in New York: NASDAQ 100 startet in der Gewinnzone
24.12.24		NYSE-Handel: Dow Jones beginnt Dienstagshandel mit Gewinnen

24.12.24

Börse New York: Dow Jones zeigt sich zum Handelsende fester

24.12.24

Zuversicht in New York: Dow Jones am Dienstagnachmittag mit Gewinnen

24.12.24

Dow Jones-Handel aktuell: Dow Jones steigt am Dienstagmittag

24.12.24

Börse New York: NASDAQ 100-Anleger greifen am Dienstagmittag zu

24.12.24

Freundlicher Handel: Letztendlich Gewinne im Euro STOXX 50

24.12.24

Dienstagshandel in New York: NASDAQ 100 startet in der Gewinnzone